News
AT&T Inc.'s $5.75B Lumen deal offers minimal impact and distracts from growth. Click for my updated look at T stock and why I ...
Given macroeconomic developments and Fed comments, here are two high-yield stocks to thrive in uncertain markets. Click to read my long-term strategy for income and growth.
14d
Zacks.com on MSN3 Dividend Stocks to Pick for Solid GrowthIn such a scenario, dividend investing seems the best choice as it offers consistent and safe income. Though the strategy does not offer dramatic price appreciation, it is a major source of consistent ...
5d
Zacks.com on MSNAbbott vs. Medtronic: Which Dividend-Paying MedTech Stock is Better?Year to date, shares of Abbott have jumped 18.8%, while those of Medtronic have improved 6.5%. Both the stocks outperformed ...
Smiths News continues to focus on operational efficiencies and was able to generate savings in the period of £3.0m (H124: £3.1m) which, along with the growth mentioned above, led to an increase in ...
MotoGP: CEO Neumeister: "It's part of our DNA. We build the best motorcycles in the world. Which brand will be on the ...
We recently published a list of the 20 Best Dividend Growth Stocks with High Yields. In this article, we are going to take a ...
We recently published a list of the 15 Best High-Yield Dividend Stocks for 2025 and Beyond. In this article, we are going to take a look at where Medtronic plc (NYSE:MDT) stands against other best ...
Recursion Pharmaceuticals (NasdaqGS:RXRX) reported a 10% decline in its share price last week as it announced first-quarter 2025 results with an increased net loss despite rising sales and revenue.
Recognising the need to improve both efficiency and returns from public investments, the government has launched a sweeping ...
The general meeting resolved to carry forward the net loss for the financial year 2024 in accordance with the adopted balance sheet and to no payment of dividend. The general meeting resolved to ...
How to Choose the Best Ghostwriting Company for Your Next Book? Your book idea could be worth millions—but only if it’s executed properly. The harsh truth? Most first-time authors waste years (and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results